Showing 1-19 of 19 results
Nobuko Hijiya M.D.
Funded: 01-01-2018 through 12-31-2018
Funding Type: Infrastructure Grant
Institution Location: Chicago, IL
Institution: Ann & Robert H. Lurie Children's Hospital affiliated with Northwestern University

This grant supports a Clinical Research Coordinator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Mary Lou Schmidt M.D.
Funded: 12-01-2017 through 11-30-2018
Funding Type: Infrastructure Grant
Institution Location: Chicago, IL
Institution: University of Illinois - Chicago affiliated with University Of Illinois Hospital & Health Sciences System

The AJ Renner Memorial Infrastructure Grant funds the Nurse Researchers in the UIC/Rush/Stroger COG Program to ensure more kids can be treated on clinical trials, often their best hope for a cure. AJ Renner was an amazing volunteer and donor in Chicago and a champion for kids fighting cancer.

New Approaches to Neuroblastoma Therapy (NANT) Consortium Member
Funded: 07-01-2017 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Chicago, IL
Institution: Comer Children's Hospital affiliated with The University of Chicago

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

Rush University Medical Center Summer Fellow
Funded: 06-01-2017 through 06-01-2018
Funding Type: St. Baldrick's Summer Fellow
Institution Location: Chicago, IL
Institution: Rush University Medical Center

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium Member
Funded: 07-01-2016 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Chicago, IL
Institution: The University of Chicago affiliated with Comer Children's Hospital

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric LEukemiA Precision-based Therapy (LEAP) Consortium. For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

Late Effects After High Risk Neuroblastoma – The LEAHRN Study
Funded: 07-01-2015 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Chicago, IL
Institution: The University of Chicago affiliated with Comer Children's Hospital

Modern therapies such as stem cell transplant and immune therapy have made high-risk neuroblastoma a survivable disease for some children, but little is known about the chronic health issues experienced by survivors. In order to ensure that future treatments address both the chance and the quality of cure, this consortium aims to examine the impact of neuroblastoma therapy on survivors' growth, pubertal development and long-term health. This grant is generously supported by the "Just Do It...…and be done with it" Hero Fund created in honor of Sara Martorano who doesn't let anything dim her sparkle and has a compassionate heart and smile. It also celebrates the courage of all cancer kids through treatment and the support of their family and friends.

Pediatric Blood & Marrow Transplant Consortium Member
Funded: 07-01-2015 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Chicago, IL
Institution: Ann & Robert H. Lurie Children's Hospital affiliated with Northwestern University

This institution is a member of a research consortium which is being funded by St. Baldrick's: Pediatric Blood & Marrow Transplant Consortium. For a description of this project, see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Evanston, IL
Institution: NorthShore University Health System

This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.

New Approaches to Neuroblastoma Therapy (NANT) Consortium Member
Funded: 07-01-2014 through 06-30-2018
Funding Type: Consortium Research Grant
Institution Location: Chicago, IL
Institution: The University of Chicago affiliated with Comer Children's Hospital

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

Children's Oncology Group Member
Funded: 07-01-2005 through 06-30-2018
Funding Type: Cooperative Research Grant (COG)
Institution Location: Chicago, IL
Institution: The University of Chicago affiliated with Comer Children's Hospital

This institution is a member of the Children's Oncology Group (COG). From the first event in 2000 until 2004, St. Baldrick's funds benefited the COG. Since the St. Baldrick's Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick's grant every year. These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.

Children's Oncology Group Member
Funded: 07-01-2005 through 06-30-2018
Funding Type: Cooperative Research Grant (COG)
Institution Location: Chicago, IL
Institution: University of Illinois - Chicago affiliated with University Of Illinois Hospital & Health Sciences System

This institution is a member of the Children's Oncology Group (COG). From the first event in 2000 until 2004, St. Baldrick's funds benefited the COG. Since the St. Baldrick's Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick's grant every year. These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.

Children's Oncology Group Member
Funded: 07-01-2005 through 06-30-2018
Funding Type: Cooperative Research Grant (COG)
Institution Location: Chicago, IL
Institution: Ann & Robert H. Lurie Children's Hospital affiliated with Northwestern University

This institution is a member of the Children's Oncology Group (COG). From the first event in 2000 until 2004, St. Baldrick's funds benefited the COG. Since the St. Baldrick's Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick's grant every year. These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.

Children's Oncology Group Member
Funded: 07-01-2005 through 06-30-2018
Funding Type: Cooperative Research Grant (COG)
Institution Location: Chicago, IL
Institution: Rush University Medical Center

This institution is a member of the Children's Oncology Group (COG). From the first event in 2000 until 2004, St. Baldrick's funds benefited the COG. Since the St. Baldrick's Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick's grant every year. These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.

Children's Oncology Group Member
Funded: 07-01-2005 through 06-30-2018
Funding Type: Cooperative Research Grant (COG)
Institution Location: Maywood, IL
Institution: Loyola University of Chicago affiliated with Cardinal Bernardin Cancer Center, Ronald McDonald Children's Hospital

This institution is a member of the Children's Oncology Group (COG). From the first event in 2000 until 2004, St. Baldrick's funds benefited the COG. Since the St. Baldrick's Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick's grant every year. These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.

Children's Oncology Group Member
Funded: 07-01-2005 through 06-30-2018
Funding Type: Cooperative Research Grant (COG)
Institution Location: Oak Lawn, IL
Institution: Advocate Children's Hospital - Oak Lawn

This institution is a member of the Children's Oncology Group (COG). From the first event in 2000 until 2004, St. Baldrick's funds benefited the COG. Since the St. Baldrick's Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick's grant every year. These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.

Children's Oncology Group Member
Funded: 07-01-2005 through 06-30-2018
Funding Type: Cooperative Research Grant (COG)
Institution Location: Park Ridge, IL
Institution: Advocate Children's Hospital - Park Ridge

This institution is a member of the Children's Oncology Group (COG). From the first event in 2000 until 2004, St. Baldrick's funds benefited the COG. Since the St. Baldrick's Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick's grant every year. These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.

Children’s Oncology Group Member
Funded: 07-01-2005 through 06-30-2018
Funding Type: Cooperative Research Grant (COG)
Institution Location: Park Ridge, IL
Institution: Advocate Children's Hospital-Park Ridge

This institution is a member of the Children's Oncology Group (COG). From the first event in 2000 until 2004, St. Baldrick's funds benefited the COG. Since the St. Baldrick's Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick's grant every year. These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.

Children's Oncology Group Member
Funded: 07-01-2005 through 06-30-2018
Funding Type: Cooperative Research Grant (COG)
Institution Location: Peoria, IL
Institution: Children’s Hospital of Illinois at OSF-Saint Francis Medical Center

This institution is a member of the Children’s Oncology Group (COG).  From the first event in 2000 through 2004, St. Baldrick’s funds benefitted the COG.  Since the St. Baldrick’s Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick’s grant every year.  These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.

Children's Oncology Group Member
Funded: 07-01-2005 through 06-30-2018
Funding Type: Cooperative Research Grant (COG)
Institution Location: Springfield, IL
Institution: Southern Illinois University, Medical School

This institution is a member of the Children's Oncology Group (COG). From the first event in 2000 until 2004, St. Baldrick's funds benefited the COG. Since the St. Baldrick's Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick's grant every year. These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.